Novel Immunotherapeutics for Inflammatory Injury, Fibrosis and Vascular Leak

Uncontrolled inflammation and vascular leakage are at the core of life-threatening disease, but effective treatments remain limited.

At Aqualung Therapeutics, we are developing targeted therapies to interrupt these processes at their source, with the potential to redefine treatment and improve outcomes for patients worldwide.